Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
EDAP TMS to hold an expert panel » 07:50
09/29/22
09/29
07:50
09/29/22
07:50
EDAP

EDAP TMS

$8.08 /

+0.08 (+1.00%)

CEO Oczachowski hosts an…

CEO Oczachowski hosts an Urology Expert Panel and live Focal One technology demonstration in New York on September 29 at 8 am. Webcast Link

ShowHide Related Items >><<
EDAP EDAP TMS
$8.08 /

+0.08 (+1.00%)

EDAP EDAP TMS
$8.08 /

+0.08 (+1.00%)

05/18/22 Piper Sandler
EDAP TMS price target lowered to $11 from $13 at Piper Sandler
11/19/21 B. Riley
EDAP TMS price target lowered to $10 from $13 at B. Riley
EDAP EDAP TMS
$8.08 /

+0.08 (+1.00%)

  • 23
    Sep
EDAP EDAP TMS
$8.08 /

+0.08 (+1.00%)

Conference/Events
EDAP TMS to hold an expert panel » 04:55
09/29/22
09/29
04:55
09/29/22
04:55
EDAP

EDAP TMS

$8.08 /

+0.08 (+1.00%)

CEO Oczachowski hosts an…

CEO Oczachowski hosts an Urology Expert Panel and live Focal One technology demonstration in New York on September 29 at 8 am. Webcast Link

ShowHide Related Items >><<
EDAP EDAP TMS
$8.08 /

+0.08 (+1.00%)

EDAP EDAP TMS
$8.08 /

+0.08 (+1.00%)

05/18/22 Piper Sandler
EDAP TMS price target lowered to $11 from $13 at Piper Sandler
11/19/21 B. Riley
EDAP TMS price target lowered to $10 from $13 at B. Riley
EDAP EDAP TMS
$8.08 /

+0.08 (+1.00%)

  • 23
    Sep
EDAP EDAP TMS
$8.08 /

+0.08 (+1.00%)

Yesterday
Conference/Events
EDAP TMS to hold an expert panel » 23:57
09/28/22
09/28
23:57
09/28/22
23:57
EDAP

EDAP TMS

$8.08 /

+0.08 (+1.00%)

CEO Oczachowski hosts an…

CEO Oczachowski hosts an Urology Expert Panel and live Focal One technology demonstration in New York on September 29 at 8 am. Webcast Link

ShowHide Related Items >><<
EDAP EDAP TMS
$8.08 /

+0.08 (+1.00%)

EDAP EDAP TMS
$8.08 /

+0.08 (+1.00%)

05/18/22 Piper Sandler
EDAP TMS price target lowered to $11 from $13 at Piper Sandler
11/19/21 B. Riley
EDAP TMS price target lowered to $10 from $13 at B. Riley
EDAP EDAP TMS
$8.08 /

+0.08 (+1.00%)

  • 23
    Sep
EDAP EDAP TMS
$8.08 /

+0.08 (+1.00%)

Over a week ago
Syndicate
EDAP TMS 2.67M share Spot Secondary priced at $7.50 » 20:58
09/22/22
09/22
20:58
09/22/22
20:58
EDAP

EDAP TMS

$8.58 /

-0.325 (-3.65%)

The deal priced below…

The deal priced below last closing price of $8.57. Jefferies is acting as sole book running manager for the offering.

ShowHide Related Items >><<
EDAP EDAP TMS
$8.58 /

-0.325 (-3.65%)

EDAP EDAP TMS
$8.58 /

-0.325 (-3.65%)

05/18/22 Piper Sandler
EDAP TMS price target lowered to $11 from $13 at Piper Sandler
11/19/21 B. Riley
EDAP TMS price target lowered to $10 from $13 at B. Riley
EDAP EDAP TMS
$8.58 /

-0.325 (-3.65%)

  • 23
    Sep
EDAP EDAP TMS
$8.58 /

-0.325 (-3.65%)

On The Fly
Fly Intel: After-Hours Movers » 17:54
09/22/22
09/22
17:54
09/22/22
17:54
FLUX

Flux Power

$2.53 /

-0.34 (-11.85%)

, CAMP

CalAmp

$4.89 /

-0.065 (-1.31%)

, DLNG

Dynagas LNG

$3.33 /

-0.04 (-1.19%)

, GWRE

Guidewire

$59.46 /

-1.46 (-2.40%)

, RSSS

Research Solutions

$1.85 /

-0.01 (-0.54%)

, COST

Costco

$487.20 /

-6.64 (-1.34%)

, EDAP

EDAP TMS

$8.58 /

-0.325 (-3.65%)

, TRVI

Trevi Therapeutics

$1.94 /

-0.265 (-12.02%)

, APEI

American Public Education

$8.30 /

-0.06 (-0.72%)

Check out this evening's…

ShowHide Related Items >><<
TRVI Trevi Therapeutics
$1.94 /

-0.265 (-12.02%)

GWRE Guidewire
$59.46 /

-1.46 (-2.40%)

FLUX Flux Power
$2.53 /

-0.34 (-11.85%)

EDAP EDAP TMS
$8.58 /

-0.325 (-3.65%)

DLNG Dynagas LNG
$3.33 /

-0.04 (-1.19%)

COST Costco
$487.20 /

-6.64 (-1.34%)

CAMP CalAmp
$4.89 /

-0.065 (-1.31%)

APEI American Public Education
$8.30 /

-0.06 (-0.72%)

FLUX Flux Power
$2.53 /

-0.34 (-11.85%)

02/11/22 Maxim
Flux Power price target lowered to $8 from $13 at Maxim
10/05/21 H.C. Wainwright
Flux Power initiated with a Buy at H.C. Wainwright
09/28/21 Maxim
Flux Power price target lowered to $13 from $15 at Maxim
CAMP CalAmp
$4.89 /

-0.065 (-1.31%)

08/16/22 Craig-Hallum
Craig-Hallum upgrades CalAmp to Buy, raises price target to $10
08/16/22 Craig-Hallum
CalAmp upgraded to Buy from Hold at Craig-Hallum
06/24/22 Goldman Sachs
Goldman Sachs cuts CalAmp EBITDA estimates on lower margin forecasts
03/25/22 Jefferies
CalAmp price target lowered to $13 from $16 at Jefferies
DLNG Dynagas LNG
$3.33 /

-0.04 (-1.19%)

04/27/22 Jefferies
Dynagas LNG reinstated with a Hold at Jefferies
GWRE Guidewire
$59.46 /

-1.46 (-2.40%)

09/12/22 Citi
Guidewire price target lowered to $79 from $88 at Citi
09/08/22 Baird
Guidewire price target lowered to $81 from $99 at Baird
09/07/22 JMP Securities
Guidewire price target lowered to $95 from $110 at JMP Securities
09/07/22 RBC Capital
Guidewire price target lowered to $100 from $125 at RBC Capital
RSSS Research Solutions
$1.85 /

-0.01 (-0.54%)

COST Costco
$487.20 /

-6.64 (-1.34%)

09/21/22 Deutsche Bank
Costco price target raised to $581 from $579 at Deutsche Bank
09/12/22 UBS
Costco likely to post 'healthy upside' in Q4, says UBS
09/01/22 Loop Capital
Costco price target lowered to $585 from $610 at Loop Capital
08/31/22 Baird
Costco sales remain resilient, says Baird
EDAP EDAP TMS
$8.58 /

-0.325 (-3.65%)

05/18/22 Piper Sandler
EDAP TMS price target lowered to $11 from $13 at Piper Sandler
11/19/21 B. Riley
EDAP TMS price target lowered to $10 from $13 at B. Riley
TRVI Trevi Therapeutics
$1.94 /

-0.265 (-12.02%)

06/29/22 Needham
Trevi Therapeutics price target raised to $10 from $8 at Needham
05/24/22 Oppenheimer
Trevi Therapeutics initiated with an Outperform at Oppenheimer
03/29/22 Aegis
Trevi Therapeutics initiated with a Buy at Aegis
APEI American Public Education
$8.30 /

-0.06 (-0.72%)

08/11/22 Truist
American Public Education price target lowered to $16 from $21 at Truist
08/10/22 Barrington
American Public Education price target lowered to $15 from $20 at Barrington
05/12/22 Truist
American Public Education price target lowered to $21 from $26 at Truist
05/11/22 Barrington
American Public Education price target lowered to $20 from $25 at Barrington
TRVI Trevi Therapeutics
$1.94 /

-0.265 (-12.02%)

RSSS Research Solutions
$1.85 /

-0.01 (-0.54%)

GWRE Guidewire
$59.46 /

-1.46 (-2.40%)

FLUX Flux Power
$2.53 /

-0.34 (-11.85%)

EDAP EDAP TMS
$8.58 /

-0.325 (-3.65%)

DLNG Dynagas LNG
$3.33 /

-0.04 (-1.19%)

COST Costco
$487.20 /

-6.64 (-1.34%)

CAMP CalAmp
$4.89 /

-0.065 (-1.31%)

APEI American Public Education
$8.30 /

-0.06 (-0.72%)

  • 23
    Sep
  • 23
    Sep
COST Costco
$487.20 /

-6.64 (-1.34%)

GWRE Guidewire
$59.46 /

-1.46 (-2.40%)

FLUX Flux Power
$2.53 /

-0.34 (-11.85%)

COST Costco
$487.20 /

-6.64 (-1.34%)

CAMP CalAmp
$4.89 /

-0.065 (-1.31%)

TRVI Trevi Therapeutics
$1.94 /

-0.265 (-12.02%)

COST Costco
$487.20 /

-6.64 (-1.34%)

Syndicate
EDAP TMS files to sell common stock, no amount given » 16:02
09/22/22
09/22
16:02
09/22/22
16:02
EDAP

EDAP TMS

$8.60 /

-0.3 (-3.37%)

Jefferies LLC is acting…

Jefferies LLC is acting as the sole book-running manager for the offering.

ShowHide Related Items >><<
EDAP EDAP TMS
$8.60 /

-0.3 (-3.37%)

EDAP EDAP TMS
$8.60 /

-0.3 (-3.37%)

05/18/22 Piper Sandler
EDAP TMS price target lowered to $11 from $13 at Piper Sandler
11/19/21 B. Riley
EDAP TMS price target lowered to $10 from $13 at B. Riley
EDAP EDAP TMS
$8.60 /

-0.3 (-3.37%)

Syndicate
EDAP TMS files to sell common stock, no amount given » 16:02
09/22/22
09/22
16:02
09/22/22
16:02
EDAP

EDAP TMS

$8.60 /

-0.3 (-3.37%)

Jefferies LLC is acting…

Jefferies LLC is acting as the sole book-running manager for the offering.

ShowHide Related Items >><<
EDAP EDAP TMS
$8.60 /

-0.3 (-3.37%)

EDAP EDAP TMS
$8.60 /

-0.3 (-3.37%)

05/18/22 Piper Sandler
EDAP TMS price target lowered to $11 from $13 at Piper Sandler
11/19/21 B. Riley
EDAP TMS price target lowered to $10 from $13 at B. Riley
EDAP EDAP TMS
$8.60 /

-0.3 (-3.37%)

Over a month ago
Earnings
EDAP TMS reports Q2 EPS 6c, consensus (3c) » 16:38
08/24/22
08/24
16:38
08/24/22
16:38
EDAP

EDAP TMS

$7.23 /

+0.03 (+0.42%)

Reports Q2 revenue…

Reports Q2 revenue $15.0M, consensus $13.11M. CEO Marc Oczachowski said: "For Q2, we generated strong year-over-year revenue growth of nearly 37% driven by contribution from all three business segments, including our core HIFU business, which grew nearly 50% over the prior year period...Our pipeline of sales prospects continues to grow, driven by a combination of new world-renowned healthcare institutions that have adopted Focal One, and champion this technology, and our growing presence at important medical meetings such as the annual meeting of the American Urological Association this past May. These trends, together with the proposed increase in reimbursement for CY23 indicated in the preliminary CMS Outpatient Prospective Payment System rule, give me great optimism for the future adoption of our Focal One platform".

ShowHide Related Items >><<
EDAP EDAP TMS
$7.23 /

+0.03 (+0.42%)

EDAP EDAP TMS
$7.23 /

+0.03 (+0.42%)

05/18/22 Piper Sandler
EDAP TMS price target lowered to $11 from $13 at Piper Sandler
11/19/21 B. Riley
EDAP TMS price target lowered to $10 from $13 at B. Riley
EDAP EDAP TMS
$7.23 /

+0.03 (+0.42%)

Hot Stocks
EDAP TMS announces Focal One HIFU reimbursement raised to urology APC level 6 » 07:07
07/18/22
07/18
07:07
07/18/22
07:07
EDAP

EDAP TMS

$6.35 /

+0.03 (+0.47%)

EDAP TMS announced that…

EDAP TMS announced that the U.S. Centers for Medicare and Medicaid Services, CMS, has released its proposed outpatient prospective payment system, OPPS, reimbursement rule for calendar year 2023, CY23. For a hospital performing a Focal One HIFU prostate ablation on an outpatient basis, the proposed rule would increase the reimbursement level to an Ambulatory Payment Classification, APC, level 6, as compared to APC level 5 currently. This would result in an increase in reimbursement to a hospital performing a HIFU procedure on a Medicare patient to $8,711 per procedure as a national average, adjusted locally based on the wage index, as compared to $4,506 currently as a national average, adjusted locally based on the wage index. The increase to APC level 6 has positive implications for patients beyond Medicare since many commercial payors have begun to cover focal HIFU for their members. Commercial payment and access policies are influenced by Medicare policy and reimbursement decisions.

ShowHide Related Items >><<
EDAP EDAP TMS
$6.35 /

+0.03 (+0.47%)

EDAP EDAP TMS
$6.35 /

+0.03 (+0.47%)

05/18/22 Piper Sandler
EDAP TMS price target lowered to $11 from $13 at Piper Sandler
11/19/21 B. Riley
EDAP TMS price target lowered to $10 from $13 at B. Riley
EDAP EDAP TMS
$6.35 /

+0.03 (+0.47%)

Over a quarter ago
Hot Stocks
EDAP TMS announces oral presentations at ISTU » 08:03
06/06/22
06/06
08:03
06/06/22
08:03
EDAP

EDAP TMS

$6.90 /

-0.1 (-1.43%)

EDAP TMS announced that…

EDAP TMS announced that three oral presentations will be delivered on its HIFU developments at the 21st Annual International Symposium on Therapeutic Ultrasound, which is being held June 7-10, in Toronto and virtually. Marc Oczachowski, EDAP's Chairman and Chief Executive Officer, said, "We are very pleased to have several noteworthy abstracts presented at this year's ISTU annual meeting. We believe that high intensity focused ultrasound has broad clinical utility, well beyond our Focal One core prostate cancer technology platform, and we look forward to presenting these compelling findings." Details of the presentations are as follows: Transrectal High-intensity focused ultrasoundfor the management of rectal Deep Infiltrating Endometriosis: Results of phase I clinical trials: Pr. Dubernard will present the multicentric prospective 60-patient study designed to confirm the feasibility of transrectal HIFU treatment for patients with symptomatic rectal endometriosis and to assess its safety and clinical efficiencies. The investigators conclude that HIFU can be a feasible therapy for rectal endometriosis and could be an interesting minimally invasive alternative to surgery for the treatment of rectosigmoid endometriosis if its efficacy and safety are confirmed. Comparison of HIFU lesion monitoring techniques based on B-mode images: Different monitoring techniques will be presented based on B-mode images acquired for HIFU lesion detection and applied in the context of prostate cancer. Lesion monitoring is crucial to HIFU control in clinical applications. However, open-access, ultrafast US scanners are generally not available in this setting. Four techniques based on B-mode ultrasound images were developed and compared, including passive elastography. The investigators concluded that PE demonstrated precise lesion detection, independent from uncontrolled bubble appearance. Preclinical Evaluation of a Dual-Mode CMUT Probe for Ultrasound-Guided HIFU Treatment: Dr. Suarez-Castellanos demonstrates the technical feasibility of using an ultrasound-guided high intensity focused ultrasound probe, fully developed using capacitive micromachined ultrasonic transducers. The HIFU-CMUT array showed tissue ablation capabilities with volumes compatible with localized cancer targeting, while allowing integration of an imaging array for improved visualization of targeted tissues, thus providing assets for further development of focal therapies.

ShowHide Related Items >><<
EDAP EDAP TMS
$6.90 /

-0.1 (-1.43%)

EDAP EDAP TMS
$6.90 /

-0.1 (-1.43%)

05/18/22 Piper Sandler
EDAP TMS price target lowered to $11 from $13 at Piper Sandler
11/19/21 B. Riley
EDAP TMS price target lowered to $10 from $13 at B. Riley
EDAP EDAP TMS
$6.90 /

-0.1 (-1.43%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.